Details:

Scientific Organizers: John D. Carpten, David Solit and Chanita Hughes-Halbert

Date & Location: January 12-15, 2025  | Beaver Run Conference Center, Breckenridge, CO, United States

Share Link: https://keysym.us/KSPrecisionOnc25

Deadlines:

Scholarship Deadline: October 29, 2024

Short Talk Abstract Deadline: October 29, 2024

Poster Abstract Deadline: December 19, 2024

Early Registration Deadline: November 21, 2024

Session Topics:

• Targeted Therapeutics

• Clinical Trial Advances/Insights/Design

• Precision Oncology and Disparities (Implementation and Discovery)

• Data Science, Informatics, AI & Machine Learning  

• Technologies for Biomarker Discovery (Discovery Through Application in the Clinic)

• Precision Immuno-oncology / Overcoming Immune Evasion Through Combination Therapies 

In the past decade, Precision Medicine has significantly advanced the field of oncology by considering individual variability in genes, environment, and lifestyle for disease treatment and prevention.  Specifically, new technologies and biomedical informatics tools have allowed for rapid matching of targeted cancer therapies to tumors harboring specific genetic mutations or genetic biomarkers associated with drug efficacy. Recent efforts have enabled drug development against previous “undruggable” targets such as KRAS, further empowering oncologists to treat patients more effectively. Yet, with all of the progress and impact that Precision Oncology has had on patient outcomes, these benefits have not been available equitably, especially considering patients from underrepresented groups.

This meeting will bring together thought leaders across the continuum of translational and clinical cancer research to highlight recent advances and progress in Precision Oncology, including targeted therapeutic development, innovations in technologies for molecular profiling, and Precision Oncology clinical trial updates. The meeting will also address a major gap in current Precision Oncology approaches, namely the lack of diversity in discovery datasets and clinical trials, as well as disparities in access to these healthcare innovations. We will discuss the sources and impacts of these deficiencies, and strategies to correct them. The outcomes of this meeting will improve our ability to develop and implement the most effective approaches for precision care and accelerate clinical advances for ALL cancer patients, across diverse demographics.

Check out other conferences here: https://www.keystonesymposia.org/conferences/conference-listing?mtg_title=&mtg_type=&mtg_venue=&mtg_category=&time_range=today-forward&utm_campaign=Journals&utm_source=Journals&utm_medium=0&utm_term=Colorado%20Meetings%20-%20Other%20Institutions&utm_content=All%20Conferences